KUALA LUMPUR: Nasdaq-listed Agape ATP Corporation (ATPC) has signed three memorandums of understanding (MoUs) with prominent healthcare institutions in Indonesia.
The MoUs were signed with Dr Sardjito General Hospital in Yogyakarta, Dr H. A. Rotinsulu Lung Hospital in Bandung and Dr M. Goenawan Partowidigdo Respiratory Hospital in Bogor.
According to ATPC, the partnership aims to advance medical research, introduce innovative treatment strategies and strengthen training programs to address respiratory diseases such as tuberculosis (TB) and chronic obstructive pulmonary disease (COPD).
It added that the signing marks a key milestone in its strategic expansion plans in Indonesia and Southeast Asia.
Furthermore, ATPC said the partnerships focus on enhancing research capabilities, fostering medical innovations, and conducting clinical studies on ATPC's existing health products.
The studies ensure the products comply with Indonesian health standards for safe consumption and use, meeting regulatory requirements prior to market distribution of ATPC's products.
ATPC founder and global group chief executive officer Prof Datuk Seri Dr How Kok Choong said TB and COPD remain major public health concerns in both Indonesia and Malaysia.
Indonesia ranks among the countries with the highest TB burden globally, with hundreds of thousands of new cases reported annually.
"Meanwhile, COPD, often linked to high rates of smoking and air pollution, significantly contributes to illness and mortality in both nations.
"These diseases place immense strain on healthcare systems, highlighting the urgent need for collaborative efforts to improve prevention, diagnosis, and treatment strategies," he said in a statement today.
He said by conducting rigorous clinical studies and aligning with Indonesia's Ministry of Health standards, the company aims to ensure that products and services like DSY Wellness, ATP2 and LEGA effectively meet the needs of patients battling respiratory diseases.
"This marks a pivotal step toward creating a healthier, more sustainable future," he noted.
The partnerships also emphasise the integration of sustainable medical innovations, aiming to enhance long-term well-being and align with the United Nations Sustainable Development Goals.